Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
151.93
-5.33 (-3.39%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Nutex Health Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 846.72 | 875.26 | 479.95 | 247.65 | 219.29 | 331.53 |
Revenue Growth | 6.88% | 82.36% | 93.80% | 12.93% | -33.85% | 20.98% |
Gross Profit Gross Profit Growth | 434.03 | 444.28 | 196.26 | 34.77 | 15.42 | 179.28 |
Operating Income Operating Income Growth | 364.27 | 275.63 | 130.7 | -31.77 | -406.6 | 170.26 |
Net Income Net Income Growth | 179.92 | 70.79 | 52.1 | -45.79 | -424.78 | 132.59 |
Earnings Per Share EPS Growth | 25.27 | 10.48 | 9.69 | -10.39 | 9.69 | -10.39 |
EPS Growth | 158.38% | 8.15% | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Hospital Division Hospital Division Growth | 844.16 | 449.06 | 218.07 | 198.51 | 331.53 |
Population Health Management Division Population Health Management Division Growth | 31.1 | 30.89 | 29.58 | 20.79 | - |
Real Estate Division Real Estate Division Growth | 2.49 | 2.42 | -0.8 | 0.27 | 10.47 |
Inter-segment Inter-segment Growth | -2.49 | -2.42 | 0.8 | -0.27 | -10.47 |
Total Total Growth | 875.26 | 479.95 | 247.65 | 219.29 | 331.53 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 205.21 | 185.57 | 40.64 | 22 | 34.26 | 36.12 |
Total Debt Total Debt Growth | 347.34 | 351.39 | 340.3 | 275.76 | 267.2 | 178.55 |
Net Cash (Debt) Net Cash Growth | -142.13 | -165.82 | -299.66 | -253.75 | -232.95 | -142.43 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -19.93 | -24.54 | -54.57 | -57.56 | -53.74 | -36.04 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 279.62 | 248.13 | 23.15 | 1.26 | 50.61 | 173.43 |
Capital Expenditures CapEx Growth | -5.45 | -2.53 | -2.3 | -9.5 | -14.63 | -36.93 |
Free Cash Flow Free Cash Flow Growth | 274.17 | 245.6 | 20.85 | -8.24 | 35.97 | 136.51 |
Free Cash Flow Growth | 229.38% | 1077.99% | - | - | -73.65% | 435.68% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 51.26% | 50.76% | 40.89% | 14.04% | 7.03% | 54.08% |
Operating Margin | 43.02% | 31.49% | 27.23% | -12.83% | -185.41% | 51.36% |
Pretax Margin | 40.57% | 27.97% | 22.88% | -19.58% | -191.36% | 51.12% |
Profit Margin | 32.18% | 20.61% | 19.75% | -17.53% | -197.33% | 50.83% |
FCF Margin | 32.38% | 28.06% | 4.34% | -3.33% | 16.40% | 41.17% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.00 | 15.71 | 3.27 | - | 29.41 | - |
Forward PE | 6.84 | 9.41 | 53.71 | - | - | - |
P/FCF Ratio | 3.85 | 4.75 | 8.38 | - | 34.34 | - |
PS Ratio | 1.23 | 1.33 | 0.36 | 0.49 | 5.63 | - |